Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetic study of intranasal CT001 in children undergoing elective surgical procedures
2021-000137-14Phase 2Completed
- Sponsor
- Cessatech
- Start
- Mar 2021
- Modality
- Blood Coagulation Factors → Therapeutic Enzymes → Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of CT001 in acute pain, sponsored by Cessatech. Primary endpoint: Pharmacokinetics of intranasal CT001. Started Mar 2021; status: completed.
02
Drugs
CT001
03
Conditions
acute pain
Beyond the preview
Go deeper on 2021-000137-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-000137-14.